Nivolumab now available for lung cancer after company offers NICE new CDF deal
Lung cancer patients in England can now be prescribed nivolumab, also known as Opdivo, after NICE says it should be available through the Cancer Drugs Fund (CDF).
NICE to begin review of its guidance on the diagnosis and treatment of CFS/ME
NICE is to begin a review of its 2010 guideline on the diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) following a recent public consultation with patient and professional groups.
More than a million people should be offered lifestyle tips as a way to avoid type 2 diabetes
People at the highest risk of type 2 diabetes should be given intensive exercise and weight loss help by the NHS, NICE has recommended.
Sepsis - what NICE says
NICE urges all professionals across the NHS to think 'could this be sepsis?' Find out what else NICE says to tackle this life-threatening condition.
Latest news headlines
-
Look out for people at risk of having ADHD diagnosis missed, says NICE
NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.
06 September 2017
-
Suspect endometriosis in women with chronic pelvic pain, says NICE.
Delayed diagnosis is a significant problem for women with endometriosis, NICE has said, as new guidance aims to raise awareness amongst healthcare professionals.
06 September 2017
-
NICE says benefits of breast cancer drug fulvestrant too uncertain to make it cost effective
NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast cancer does not prove it prolongs survival more than existing, less expensive treatments.
01 September 2017
-
People should have more control of social care services
NICE is urging councils in England to help adults have more control over day-to-day tasks like cooking and cleaning.
22 August 2017
-
Local councils should make it easier for people with disabilities to be active, says NICE
NICE is urging local councils to make it as easy as possible for people with limited mobility to be more active in their area.
21 August 2017
-
Patients getting faster access to cancer drugs as NICE approves three quarters of the Cancer Drugs Fund
Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.
10 August 2017